Terms: = Brain cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
448 results:
1. A comparative study of whole brain radiotherapy with concomitant thalidomide versus whole brain radiotherapy alone in brain metastases.
Chyrmang D; Devi YS; Baidya K; Singh LJ; Nongrum DL; Devi ND
J Cancer Res Ther; 2024 Jan; 20(1):255-260. PubMed ID: 38554330
[TBL] [Abstract] [Full Text] [Related]
2. Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast cancer with brain Metastases.
Wang C; Xiang J; Zhang Q; Li J; Liu Y; Liu J
Drug Des Devel Ther; 2024; 18():909-917. PubMed ID: 38545432
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch repair status and surgical approach in apparent early-stage endometrial cancer.
Morton R; Webb PM; Na R; Obermair A; Farrell R
Int J Gynecol Cancer; 2024 Apr; 34(4):535-543. PubMed ID: 38431289
[TBL] [Abstract] [Full Text] [Related]
5. Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport.
Finlayson L; McMillan L; Suveges S; Steele D; Eftimie R; Trucu D; Brown CTA; Eadie E; Hossain-Ibrahim K; Wood K
J Biomed Opt; 2024 Feb; 29(2):025001. PubMed ID: 38322729
[TBL] [Abstract] [Full Text] [Related]
6. brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast cancer and brain Metastases: A Nonrandomized Phase 2 Trial.
Yang Z; Meng J; Mei X; Mo M; Xiao Q; Han X; Zhang L; Shi W; Chen X; Ma J; Palmer J; Shao Z; Zhang Z; Yu X; Guo X
JAMA Oncol; 2024 Mar; 10(3):335-341. PubMed ID: 38175627
[TBL] [Abstract] [Full Text] [Related]
7. Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer.
Kim K; Kim H; Shin I; Noh SJ; Kim JY; Suh KJ; Kim YN; Lee JY; Cho DY; Kim SH; Kim JH; Lee SH; Choi JK
Sci Rep; 2023 Dec; 13(1):22482. PubMed ID: 38110532
[TBL] [Abstract] [Full Text] [Related]
8. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
[TBL] [Abstract] [Full Text] [Related]
9. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; ; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; Sangro B; D'Alessio A; Scheiner B; Pinato DJ; Pinter M; Paradis V; Beaufrère A; Peter S; Rimassa L; Di Tommaso L; Vogel A; Michalak S; Boursier J; Loménie N; Ziol M; Calderaro J
Lancet Oncol; 2023 Dec; 24(12):1411-1422. PubMed ID: 37951222
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Albiges L; Gurney H; Atduev V; Suarez C; Climent MA; Pook D; Tomczak P; Barthelemy P; Lee JL; Stus V; Ferguson T; Wiechno P; Gokmen E; Lacombe L; Gedye C; Perini RF; Sharma M; Peng X; Lee CH
Lancet Oncol; 2023 Aug; 24(8):881-891. PubMed ID: 37451291
[TBL] [Abstract] [Full Text] [Related]
11. Antineoplastic effects of cassava-cyanide extract on human glioblastoma (LN229) cells.
S S; Tom J; V P S; U V; Xavier J; C A J; P V M
Toxicon; 2023 Aug; 232():107200. PubMed ID: 37419285
[TBL] [Abstract] [Full Text] [Related]
12. Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: a systematic review and meta-analysis of clinical characteristics.
Liu W; Huo G; Chen P
BMC Cancer; 2023 May; 23(1):458. PubMed ID: 37202730
[TBL] [Abstract] [Full Text] [Related]
13. Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer.
Cai J; Chen Y; Wang K; Li Y; Wu J; Yu H; Li Q; Wu Q; Meng W; Wang H; Lu A; Huang M; Wei G; Guan D
BMC Complement Med Ther; 2023 May; 23(1):158. PubMed ID: 37189139
[TBL] [Abstract] [Full Text] [Related]
14. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
Lapébie FX; Bura-Rivière A; Espitia O; Bongard V; Ciammaichella MM; Martínez JG; Sigüenza P; Giménez JC; Bertoletti L; Monreal M
J Thromb Haemost; 2023 Aug; 21(8):2189-2201. PubMed ID: 37068594
[TBL] [Abstract] [Full Text] [Related]
15. Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov.
Tini P; Marampon F; Giraffa M; Bucelli S; Niyazi M; Belka C; Minniti G
Radiat Oncol; 2023 Apr; 18(1):62. PubMed ID: 37016421
[TBL] [Abstract] [Full Text] [Related]
16. Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis.
Liu J; Shen B; Yang Y; Guo J; Ren W; Zhou Q; Mao J; Ye W; Wu D
Acta Oncol; 2023 Mar; 62(3):305-314. PubMed ID: 37010509
[TBL] [Abstract] [Full Text] [Related]
17. D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRAS
Li Z; Song Z; Zhao Y; Wang P; Jiang L; Gong Y; Zhou J; Jian H; Dong X; Zhuang W; Cang S; Yang N; Fang J; Shi J; Lu J; Ma R; Wu P; Zhang Y; Song M; Xu CW; Shi Z; Zhang L; Wang Y; Wang X; Zhang Y; Lu S
J Thorac Oncol; 2023 Jul; 18(7):940-951. PubMed ID: 36948246
[TBL] [Abstract] [Full Text] [Related]
18. Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
Liang L; Wen L; Qin S; He Z; Lu J; Cui R; Jiang X; Hu H; Zhong S; Li C; Yu C; Xie Y; Wang Z; Duan H; Mou Y
J Neurooncol; 2023 Apr; 162(2):327-335. PubMed ID: 36940052
[TBL] [Abstract] [Full Text] [Related]
19. Glioblastoma and Other Primary brain Malignancies in Adults: A Review.
Schaff LR; Mellinghoff IK
JAMA; 2023 Feb; 329(7):574-587. PubMed ID: 36809318
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation treatment: An Observational Study.
Veldhuizen S; Behal A; Zawertailo L; Melamed O; Agarwal M; Selby P
Can J Psychiatry; 2023 May; 68(5):359-369. PubMed ID: 36760089
[TBL] [Abstract] [Full Text] [Related]
[Next]
